Skip to main content
Wonbiogen Co.,Ltd. logo

Wonbiogen Co.,Ltd. — Investor Relations & Filings

Ticker · 307280 ISIN · KR7307280008 KO Manufacturing
Filings indexed 203 across all filing types
Latest filing 2024-03-12 AGM Information
Country KR South Korea
Listing KO 307280

Wonbiogen Co., Ltd. is a company that develops, manufactures, and sells specialized medical devices and supplies. It focuses on the research and development of new medical bio-substances and highly biocompatible medical macromolecules to create advanced wound care solutions. The company's core product offerings consist of specialized wound dressings, including polyurethane foams, soft silicone adhesive dressings, and hydrocolloid spot patches. Its portfolio is marketed under brand names such as Medisorb and Renoderm, which are designed for various applications in wound protection and management.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Wonbiogen Co., Ltd. It contains the agenda for the upcoming Annual General Meeting (AGM), including reports on business, audit, internal accounting, and proposals for financial statement approval, director appointments, and dividend approval. It also includes detailed financial statements (balance sheet, income statement, etc.) as part of the management's reference materials for the meeting. This document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the meeting and request their votes.
2024-03-12 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a resolution to convene a General Meeting of Shareholders (주주총회소집결의) for Wonbiogen. It outlines the date, location, and agenda items (financial statements, director appointments, dividends, and remuneration). This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of upcoming voting items, which falls under the Proxy Solicitation & Information Statement category.
2024-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Wonbiogen) announcing a significant change in financial structure (revenue/profit fluctuation of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for reporting preliminary financial results before the final audit report is finalized. Since it provides key financial highlights and performance metrics rather than the full annual report or a simple announcement of a report's availability, it fits best under 'Earnings Release' (ER) as it serves as the initial announcement of financial performance. FY 2023
2024-02-14 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a formal notice regarding the closure of the shareholder register and the setting of a record date for the purpose of holding an Annual General Meeting (AGM). This type of regulatory disclosure is standard for corporate governance and does not constitute the AGM presentation itself, nor is it a report publication announcement. Given the nature of the disclosure regarding shareholder rights and meeting preparation, it falls under the general regulatory filing category.
2023-12-15 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Wonbiogen regarding the setting of a record date for shareholder register closure for the purpose of cash/in-kind dividends. While it mentions dividends, it is not the final declaration of the dividend amount (which the text explicitly states will be announced later), but rather a procedural notice regarding the record date for dividend eligibility. This fits the 'Regulatory Filings' (RNS) category as it is a standard corporate disclosure of a procedural event that does not fall into the specific dividend announcement or other categories.
2023-12-15 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from Wonbiogen regarding a decision to pay cash dividends. It specifies the dividend amount per share, the dividend record date, and the total dividend amount. This falls directly under the definition of a 'Notice of Dividend Amount' (DIV).
2023-12-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.